COVID-19 - Page 8 - Research Triangle Regional Partnership

Durham’s BioCryst lands $44M contract to test anti-viral drug against COVID-19 virus

August 31, 2020

RESEARCH TRIANGLE PARK — BioCryst Pharmaceuticals has landed a $44 million contract to see if its investigational anti-viral drug, galidesivir,…

August 25, 2020

RESEARCH TRIANGLE PARK – Durham based BioAgilytix Labs has partnered with Boston’s Brio Systems to launch a platform to provide…

August 24, 2020

CLAYTON – President Donald Trump announced emergency authorization to treat COVID-19 patients with convalescent plasma — a move he called…

August 16, 2020

Novavax Inc. has locked in a deal to provide 60 million doses of its Covid-19 vaccine to the United Kingdom,…

August 14, 2020

Coming fresh off a $200 million raise, a drugmaker with a growing operation in the Triangle has received the go-ahead…

August 12, 2020

Federal health officials have tapped RTI International to join a collaboration tracking COVID-19’s ability to cause severe illness and the…

August 10, 2020

Amazon officially opened its massive fulfillment center in Garner last week, as the online shopping giant slowly ramps up what…

August 8, 2020

As more taxes and regulations are dumped on businesses in California and New York, companies are looking for outs, experts…

August 6, 2020

Could a proposed bump in California’s already high tax rate push remote workers to states like North Carolina? Experts say…